- Report
- January 2026
- 197 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 182 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 180 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 196 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 190 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- January 2026
- 199 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2026
- 485 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 483 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 184 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 380 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- October 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- July 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1314EUR$1,500USD£1,140GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1095EUR$1,250USD£950GBP
- Report
- June 2025
- 400 Pages
Global
From €4334EUR$4,949USD£3,762GBP

Valproate is a drug used to treat a variety of neurological disorders, including epilepsy, bipolar disorder, and migraine headaches. It is a type of anticonvulsant, meaning it works to reduce the frequency and severity of seizures. Valproate is also used to treat mania and depression, as well as to prevent migraine headaches. Valproate is available in both oral and intravenous forms, and is often prescribed in combination with other medications.
Valproate is a widely used drug in the Central Nervous System (CNS) drug market. It is used to treat a variety of neurological disorders, including epilepsy, bipolar disorder, and migraine headaches. Valproate is also used to treat mania and depression, as well as to prevent migraine headaches. Valproate is available in both oral and intravenous forms, and is often prescribed in combination with other medications.
Some companies in the Valproate market include AbbVie, GlaxoSmithKline, Johnson & Johnson, Pfizer, and Sanofi. Show Less Read more